BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26417914)

  • 1. DNA methylation of tumor suppressor protein-coding and non-coding genes in multiple myeloma.
    Wong KY; Chim CS
    Epigenomics; 2015; 7(6):985-1001. PubMed ID: 26417914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation of microRNA genes in multiple myeloma.
    Wong KY; Huang X; Chim CS
    Carcinogenesis; 2012 Sep; 33(9):1629-38. PubMed ID: 22715154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of methylation pattern in multiple myeloma.
    San-Miguel J; García-Sanz R; López-Pérez R
    Acta Haematol; 2005; 114 Suppl 1():23-6. PubMed ID: 16166769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma.
    Bi C; Chung TH; Huang G; Zhou J; Yan J; Ahmann GJ; Fonseca R; Chng WJ
    Oncotarget; 2015 Sep; 6(28):26508-18. PubMed ID: 26164366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-frequency promoter hypermethylation of the deleted in liver cancer-1 gene in multiple myeloma.
    Song YF; Xu R; Zhang XH; Chen BB; Chen Q; Chen YM; Xie Y
    J Clin Pathol; 2006 Sep; 59(9):947-51. PubMed ID: 16489177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma.
    Zhang Q; Wang LQ; Wong KY; Li ZY; Chim CS
    J Clin Pathol; 2015 Jul; 68(7):557-61. PubMed ID: 25855800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplexed profiling of candidate genes for CpG island methylation status using a flexible PCR/LDR/Universal Array assay.
    Cheng YW; Shawber C; Notterman D; Paty P; Barany F
    Genome Res; 2006 Feb; 16(2):282-9. PubMed ID: 16369045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
    Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
    Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of miRNA genes and oncogenesis.
    Loginov VI; Rykov SV; Fridman MV; Braga EA
    Biochemistry (Mosc); 2015 Feb; 80(2):145-62. PubMed ID: 25756530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of tumor suppressor microRNAs: lessons from lymphoid malignancies.
    Wang LQ; Liang R; Chim CS
    Expert Rev Mol Diagn; 2012 Sep; 12(7):755-65. PubMed ID: 23153241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into epigenetic regulation of microRNA-155 expression in multiple myeloma.
    Krzeminski P; Sarasquete ME; Misiewicz-Krzeminska I; Corral R; Corchete LA; Martín AA; García-Sanz R; San Miguel JF; Gutiérrez NC
    Biochim Biophys Acta; 2015 Mar; 1849(3):353-66. PubMed ID: 25497370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation changes in multiple myeloma.
    Galm O; Wilop S; Reichelt J; Jost E; Gehbauer G; Herman JG; Osieka R
    Leukemia; 2004 Oct; 18(10):1687-92. PubMed ID: 15318245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
    Kim TY; Jong HS; Song SH; Dimtchev A; Jeong SJ; Lee JW; Kim TY; Kim NK; Jung M; Bang YJ
    Oncogene; 2003 Jun; 22(25):3943-51. PubMed ID: 12813468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation.
    Li X; Liu J; Zhou R; Huang S; Huang S; Chen XM
    Br J Haematol; 2010 Jan; 148(1):69-79. PubMed ID: 19807731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
    Furuta M; Kozaki KI; Tanaka S; Arii S; Imoto I; Inazawa J
    Carcinogenesis; 2010 May; 31(5):766-76. PubMed ID: 19843643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting methylation patterns of p16, MGMT, DAPK and E-cadherin genes in multiple myeloma patients.
    Yuregir OO; Yurtcu E; Kizilkilic E; Kocer NE; Ozdogu H; Sahin FI
    Int J Lab Hematol; 2010 Apr; 32(2):142-9. PubMed ID: 19302404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasia.
    Hatzimichael E; Benetatos L; Dasoula A; Dranitsaris G; Tsiara S; Georgiou I; Syrrou M; Stebbing J; Coley HM; Crook T; Bourantas KL
    Leuk Res; 2009 Sep; 33(9):1272-5. PubMed ID: 19423161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.